LinkinLegal
Craig Titmus, photo de profil

Craig Titmus

Craig’s practice covers diverse biotechnological subject matter, with a particular focus on vaccines, diagnostics, gene therapy, therapeutic antibodies and peptides, and biofuels. Craig has significant experience of European and international patent prosecution, and coordinates global IP strategies for a range of clients including startups, SMEs, universities, large corporations and the UK Government. · Mathys & Squire LLP

EnglandIntellectual Property, Patent Prosecution

À propos

Craig advises on a broad range of biotechnological subject matter with particular focus on vaccines, diagnostics, gene therapy, therapeutic antibodies and peptides, and biofuels. He has significant experience in European and international patent prosecution and coordinates global IP strategies for clients including startups, SMEs, universities, large corporations and the UK Government.

Domaines d’expertise

Intellectual PropertyPatent ProsecutionLife Sciences / BiotechnologyVaccinesDiagnosticsGene TherapyTherapeutic Antibodies & PeptidesBiofuels

Bureau

Expertise

VaccinesDiagnosticsGene TherapyTherapeutic AntibodiesPeptidesBiofuelsEuropean and International Patent ProsecutionGlobal IP Strategy for startups, SMEs, universities, corporates and government

Formation

  • BSc (First Class) in Molecular Biology and Biochemistry, University of Durham (ranked top in his year)
  • PhD, University of Cambridge (collaboration with a multinational crop research company) — focus on environmental stress tolerance in plants and interfaces between metabolism and the cell cycle

Inscriptions au barreau

  • Chartered Institute of Patent Attorneys (CIPA) - Member
  • European Patent Institute (EPI) - Member
  • One Nucleus IP Mentor - Appointed